immatics biotechnologies GmbH (4A3) — Net Asset Quality Index
immatics biotechnologies GmbH (4A3) has a Net Asset Quality Index of 82.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €485.74 Million minus total liabilities of €86.11 Million yields net assets of €399.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read immatics biotechnologies GmbH (4A3) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
immatics biotechnologies GmbH Net Asset Quality Index Over Time (2019–2025)
This chart shows how immatics biotechnologies GmbH's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 82.3%, representing net assets of €399.62 Million against total assets of €485.74 Million EUR. For live market cap and overall valuation, see 4A3 market cap overview.
Annual Net Asset Quality Index for immatics biotechnologies GmbH (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for immatics biotechnologies GmbH from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of immatics biotechnologies GmbH to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.1% | €484.10 Million | €562.34 Million | €78.24 Million | ▲ +3.5 pp |
| 2024 | 82.6% | €574.84 Million | €696.15 Million | €121.30 Million | ▲ +38.4 pp |
| 2023 | 44.1% | €225.08 Million | €509.96 Million | €284.88 Million | ▼ -8.1 pp |
| 2022 | 52.3% | €213.16 Million | €407.82 Million | €194.66 Million | ▲ +38.5 pp |
| 2021 | 13.8% | €24.06 Million | €174.65 Million | €150.58 Million | ▼ -27.2 pp |
| 2020 | 40.9% | €104.26 Million | €254.65 Million | €150.39 Million | ▲ +71.4 pp |
| 2019 | -30.4% | €-40.84 Million | €134.28 Million | €175.11 Million | — |